Tags

Type your tag names separated by a space and hit enter

[Clinical evaluation of 30 mg cinnoxicam in patients with osteoarthrosis. Double blind controlled trial].
Minerva Med. 1996 Apr; 87(4):155-60.MM

Abstract

We tested the therapeutic response of osteoarthrosis subjects to 30 mg piroxicam cinnamate (Sinartrol). The double-blind study was conducted in 2 homogeneous groups of 30 patients each treated with piroxicam cinnamate one 30-mg tablet twice daily for 2 days followed by 1 tablet daily for further 13 days and with piroxicam cinnamate 20 mg tablets (according to the same posologic scheme) respectively. The results obtained demonstrate the efficacy of this new piroxicam cinnamate formulation which led to a significant clinical improvement, already evident after 2 days of treatment and even more evident at the end of therapy. Patients compliance to treatment was good and side effects were scarce and spontaneously subsiding.

Authors+Show Affiliations

Divisione Ortopedia e Traumatologia, Ospedale San Gerardo-Monza (Milano).

Pub Type(s)

Clinical Trial
English Abstract
Journal Article
Randomized Controlled Trial

Language

ita

PubMed ID

8700339

Citation

Peretti, G. "[Clinical Evaluation of 30 Mg Cinnoxicam in Patients With Osteoarthrosis. Double Blind Controlled Trial]." Minerva Medica, vol. 87, no. 4, 1996, pp. 155-60.
Peretti G. [Clinical evaluation of 30 mg cinnoxicam in patients with osteoarthrosis. Double blind controlled trial]. Minerva Med. 1996;87(4):155-60.
Peretti, G. (1996). [Clinical evaluation of 30 mg cinnoxicam in patients with osteoarthrosis. Double blind controlled trial]. Minerva Medica, 87(4), 155-60.
Peretti G. [Clinical Evaluation of 30 Mg Cinnoxicam in Patients With Osteoarthrosis. Double Blind Controlled Trial]. Minerva Med. 1996;87(4):155-60. PubMed PMID: 8700339.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical evaluation of 30 mg cinnoxicam in patients with osteoarthrosis. Double blind controlled trial]. A1 - Peretti,G, PY - 1996/4/1/pubmed PY - 1996/4/1/medline PY - 1996/4/1/entrez SP - 155 EP - 60 JF - Minerva medica JO - Minerva Med VL - 87 IS - 4 N2 - We tested the therapeutic response of osteoarthrosis subjects to 30 mg piroxicam cinnamate (Sinartrol). The double-blind study was conducted in 2 homogeneous groups of 30 patients each treated with piroxicam cinnamate one 30-mg tablet twice daily for 2 days followed by 1 tablet daily for further 13 days and with piroxicam cinnamate 20 mg tablets (according to the same posologic scheme) respectively. The results obtained demonstrate the efficacy of this new piroxicam cinnamate formulation which led to a significant clinical improvement, already evident after 2 days of treatment and even more evident at the end of therapy. Patients compliance to treatment was good and side effects were scarce and spontaneously subsiding. SN - 0026-4806 UR - https://www.unboundmedicine.com/medline/citation/8700339/[Clinical_evaluation_of_30_mg_cinnoxicam_in_patients_with_osteoarthrosis__Double_blind_controlled_trial]_ L2 - https://medlineplus.gov/osteoarthritis.html DB - PRIME DP - Unbound Medicine ER -